Adel Malek MD PhD

Dr. Adel Malek is a board-certified neurosurgeon in Boston specializing in the treatment of brain aneurysms and AVMs.

[Vitor Mendes Pereira @vitorpereiracan]

🚨 Study Approved in Canada!
STRIDE trial is launching to study the eShunt System — an endovascular alternative to VP shunts for normal pressure hydrocephalus (NPH).
👥 Now enrolling potential candidates
📩 [email protected]
@RADIS_lab @SmhNeuroVasc @StMichaelsFdn

[Adel Malek MD PhD @adelmalek]

Health Canada has authorized STRIDE trial for NPH treatment with the minimally invasive CereVasc eShunt® System—now enrolling in 🇨🇦🇺🇸🇦🇷. We’re proud to advance care in neuroscience.
Learn more 👉 https://t.co/9ydDQsWgO1
#CereVasc #eShunt #NPH #STRIDETrial #NeuroInnovation

[Adel Malek MD PhD @adelmalek]

https://t.co/gtfIlBZ6KF

[Adel Malek MD PhD @adelmalek]

@WThaing @CereVasc @WThaing The eShunt is an investigational device currently in a pivotal trial for adults with normal pressure hydrocephalus. It hasn’t yet received FDA approval but this Breakthrough status will enable expedited review.

[Adel Malek MD PhD @adelmalek]

Congrats to the amazing team at @CereVasc on FDA Breakthrough Device Designation for the #eShunt in pediatric patients over 12 years of age with communicating #hydrocephalus—a big step toward less invasive care for children.
🔗 [https://t.co/SHLxTlTThE]
#neurosurgery #FDA #MedTech

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: In a secondary analysis of the PACIFIC-STROKE trial, the presence of hemorrhagic infarction was not associated with worse functional outcomes. @PoojaKhatriMD @VCI_EricSmith @HanneKChr @gmdemarchis @Antonyneuro @Ash_Shoamanesh #AHAJournals https://t.co/2syMNQ40Pf

[JNIS @JNIS_BMJ]

New study shows endovascular thrombectomy (EVT) is safe and effective for acute ischemic stroke patients with pre-existing disability—a group often excluded from trials -- with good odds of returning to baseline at 90 days post-EVT. https://t.co/PNk6rgB9P6 #Stroke #Neurointervention #Thrombectomy

[CereVasc @CereVasc]

Do your patients experience shuffling feet, cognitive impairment, or incontinence? These symptoms may be normal pressure #hydrocephalus and may prequalify your patients for the STRIDE #clinicaltrial—evaluating the #endovascular eShunt® system.
Learn more: https://t.co/giszTmB1NX

[NeuroNews @NN_publishing]

.@CereVasc has reported initial results from its pilot @US_FDA-approved IDE clinical study of the eShunt system in the treatment of elderly patients with normal-pressure hydrocephalus
@CharlesMatouk @MatoukCharles
https://t.co/f7k0XQPpE3

[Amanda Baker, MD @amandaebaker]

Team @Monte_NIS enrolled another patient in the @cerevasc pilot trial for the E-shunt, an endovascular treatment for NPH 🧠💦
🙏🏻🙏🏻🙏🏻 @circleowillis
@MontefioreRAD @MonteNeurosg @NeuroMonteEinst @MontefioreNYC

[David Altschul @DavidAltschulMD]

Saw my first e-shunt today with @amandaebaker!! Thanks @MatoukCharles @YaleMed @CereVasc Amazing technology!

[Elad Levy @EladLevyMD]

After all those words, I’m at a loss for words. All I can say is thank you to everyone who has inspired and supported me on this path.

#2023CNS #IMAGINE #INNOVATE #INSPIRE

[Mohamad AbdalKader @AbdalkaderMD]

Cerebral veins: a new frontier in Neuro-IR.

https://t.co/a7zTgGJDsK

@NguyenThanhMD @ferdinandhui @MattAmansMD @eytanraz @uta_hanning @alicenomalice @WBrinjikji @adelmalek @tomoxl @BDouraied @JNeuroradiology

[SNIS Info @SNISinfo]

Do you remember our seventh Annual Meeting in Carlsbad, California? 🌊

You can look through photos from past meetings using our Flickr: https://t.co/NRrH2BekrQ

Make sure to register for our 20th Annual Meeting July 21-August 4! ➡️https://t.co/ixqjdCNITC

[ENERI - Dr. Pedro Lylyk @eneri_neuro]

Very glad to be part of this amazing project!

[BRAIN Conference @brainconferenc1]

Just Published https://t.co/TeTLyPnzmJ & just in ⌛️ for @brainconferenc1. The 1⃣ & ONLY Prof. Lylyk from the fabulous @ENERI_BSAS presenting the cutting edge E-Shunt @adelmalek @CereVasc @HydroAssoc @hydrocephalusso
@theBSNR @_the_SRT @esmintsociety @PairsNeuro @svinsociety

[Tufts Medical Center @TuftsMedicalCtr]

The eShunt System, co-invented at #TuftsMC by Neurosurgeon-in-Chief Dr. Carl Heilman & Chief of Neurovascular Surgery Dr. @adelmalek is being developed by @CereVasc as the first-ever minimally-invasive treatment for communicating hydrocephalus. https://t.co/xVemvKBBQJ

[Adel Malek MD PhD @adelmalek]

Grateful to all my colleagues and friends for making this first step possible @CereVasc @eneri_neuro @TuftsNeurosurg @TuftsMedicalCtr
First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt https://t.co/vVMmx7mkrG

[Emal Lesha, MD @emal_lesha]

Happy to see this work from my research experience at @adelmalek's lab being published @TheJNS! Check it out!

@cvsection @MemphisNSGY
@TuftsNeurosurg

https://t.co/lemr4TWzJF